Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Crippa

Showing results (181-190 of 192) with videos related to

Pageof 20
Sort By:
Toxicology and Applied Pharmacology|February 24, 2019
DMH-CBD, a cannabidiol analog with reduced cytotoxicity, inhibits TNF production by targeting NF-kB activity dependent on A<sub>2A</sub> receptorRangel L Silva, Gabriela T Silveira, Carlos W Wanderlei, et al.
Frontiers in Pharmacology|April 4, 2017
Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of Mesial Temporal Lobe EpilepsyRaquel A Do Val-da Silva, Jose E Peixoto-Santos, Ludmyla Kandratavicius, et al.
IBRO Neuroscience Reports|July 19, 2024
Genetic ablation of the isoform γ of PI3K decreases antidepressant efficacy of ketamine in male miceGabriela N Vaz, Flávia C Turcato, Isabel A V Lima, et al.
Autism Research : Official Journal of the International Society for Autism Research|November 26, 2025
Comparative Analysis of Cannabidiol and Risperidone on Behavioral and Neurochemical Outcomes, and Neurodevelopment Markers in a Zebrafish Model of Embryonic Exposure to Sodium ValproateKarla C M Costa, Tamires A V Brigante, Pedro H C Lirio, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|August 31, 2025
Prophylactic efficacy of cannabidiol and sodium nitroprusside in a ketamine-model of schizophrenia: sex-dependent effects on positive-like and cognitive impairmentsDaniel B A Prado, Matheus T Rossignoli, Rafael N Ruggiero, et al.
Brain, Behavior, & Immunity - Health|October 11, 2024
Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19Rafael R Ferreira, Ronaldo B Martins, Isabela Pires, et al.
Schizophrenia Research|December 16, 2014
Effects of minocycline add-on treatment on brain morphometry and cerebral perfusion in recent-onset schizophreniaCristiano Chaves, Cristiane R Marque, João P Maia-de-Oliveira, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 20, 2009
Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathologySagnik Bhattacharyya, Paul D Morrison, Paolo Fusar-Poli, et al.
Neuropharmacology|March 6, 2026
Cannabidiol reduces the latency for the behavioral effect of escitalopram in chronically stressed male mice: involvement of NAPE-PLD expressed in parvalbumin-positive interneurons and the prefrontal cortexFranciele F Scarante, Vinícius D Lopes, Eduardo J Fusse, et al.
Journal of Clinical Psychopharmacology|March 3, 2011
Randomized, open naturalistic, acute treatment of panic disorder with clonazepam or paroxetineAntonio E Nardi, Alexandre M Valença, Rafael C Freire, et al.
Pageof 20

Showing results (181-190 of 192) with videos related to

Sort By:
Pageof 20
Toxicology and Applied Pharmacology|February 24, 2019
DMH-CBD, a cannabidiol analog with reduced cytotoxicity, inhibits TNF production by targeting NF-kB activity dependent on A<sub>2A</sub> receptorRangel L Silva, Gabriela T Silveira, Carlos W Wanderlei, et al.
Frontiers in Pharmacology|April 4, 2017
Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of Mesial Temporal Lobe EpilepsyRaquel A Do Val-da Silva, Jose E Peixoto-Santos, Ludmyla Kandratavicius, et al.
IBRO Neuroscience Reports|July 19, 2024
Genetic ablation of the isoform γ of PI3K decreases antidepressant efficacy of ketamine in male miceGabriela N Vaz, Flávia C Turcato, Isabel A V Lima, et al.
Autism Research : Official Journal of the International Society for Autism Research|November 26, 2025
Comparative Analysis of Cannabidiol and Risperidone on Behavioral and Neurochemical Outcomes, and Neurodevelopment Markers in a Zebrafish Model of Embryonic Exposure to Sodium ValproateKarla C M Costa, Tamires A V Brigante, Pedro H C Lirio, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|August 31, 2025
Prophylactic efficacy of cannabidiol and sodium nitroprusside in a ketamine-model of schizophrenia: sex-dependent effects on positive-like and cognitive impairmentsDaniel B A Prado, Matheus T Rossignoli, Rafael N Ruggiero, et al.
Brain, Behavior, & Immunity - Health|October 11, 2024
Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19Rafael R Ferreira, Ronaldo B Martins, Isabela Pires, et al.
Schizophrenia Research|December 16, 2014
Effects of minocycline add-on treatment on brain morphometry and cerebral perfusion in recent-onset schizophreniaCristiano Chaves, Cristiane R Marque, João P Maia-de-Oliveira, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 20, 2009
Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathologySagnik Bhattacharyya, Paul D Morrison, Paolo Fusar-Poli, et al.
Neuropharmacology|March 6, 2026
Cannabidiol reduces the latency for the behavioral effect of escitalopram in chronically stressed male mice: involvement of NAPE-PLD expressed in parvalbumin-positive interneurons and the prefrontal cortexFranciele F Scarante, Vinícius D Lopes, Eduardo J Fusse, et al.
Journal of Clinical Psychopharmacology|March 3, 2011
Randomized, open naturalistic, acute treatment of panic disorder with clonazepam or paroxetineAntonio E Nardi, Alexandre M Valença, Rafael C Freire, et al.
Pageof 20